Total Liabilities: The total value of all possible claims against the corporation.
Vir Biotechnology, Inc. (VIR) had Total Liabilities of $237.55M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$68.56M |
|
$-437.99M |
|
$0.03M |
|
$68.53M |
|
$547.88M |
|
$-479.33M |
|
$41.56M |
|
$-437.77M |
|
$-437.77M |
|
$-437.99M |
|
$-437.99M |
|
$-437.99M |
|
$-437.99M |
|
$-479.33M |
|
$-458.17M |
|
138.52M |
|
138.52M |
|
$-3.16 |
|
$-3.16 |
|
| Balance Sheet Financials | |
$514.08M |
|
$55.62M |
|
$488.74M |
|
$1.00B |
|
$92.81M |
|
-- |
|
$144.73M |
|
|
Total Liabilities |
$237.55M |
$765.28M |
|
$740.49M |
|
$765.28M |
|
139.47M |
|
| Cash Flow Statement Financials | |
$-391.78M |
|
$310.37M |
|
$3.79M |
|
$318.69M |
|
$241.07M |
|
$-77.62M |
|
$49.07M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.54 |
|
-- |
|
-- |
|
-- |
|
-- |
|
99.96% |
|
-699.18% |
|
-699.18% |
|
-668.32% |
|
-638.56% |
|
-638.87% |
|
$-396.36M |
|
-- |
|
-- |
|
-- |
|
0.07 |
|
-- |
|
-- |
|
-- |
|
-57.23% |
|
-59.15% |
|
-43.68% |
|
-57.23% |
|
$5.49 |
|
$-2.86 |
|
$-2.83 |
|